AFM
ENSC icon

Anson Funds Management’s Ensysce Biosciences ENSC Stock Holding History

Anson Funds Management’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-65,568
Closed -$236K – 172
2024
Q3 		$236K Buy
+65,568
New +$398K 0.03% 137
2023
Q3 		– Sell
-2,417
Closed -$65.3K – 150
2023
Q2 		$65.3K Buy
+2,417
New +$109K 0.01% 140
2022
Q3 		– Sell
-42
Closed -$131K – 292
2022
Q2 		$131K Sell
42
-479
-92% -$1.34M 0.01% 293
2022
Q1 		$2.14M Buy
+521
New +$3.44M 0.21% 108

Other funds holding ENSC

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FIA
FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return